Structure of the Ebola virus glycoprotein spike within the virion envelope at 11 Å resolution

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Beniac, Daniel R ^a   Timothy, Booth F ^a,b  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE GLYCOPROTEIN, EBOLA VIRUS; PROTEIN BINDING; VIRUS ENVELOPE PROTEIN;

EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; HUMAN; METABOLISM; MOLECULAR MODEL; PROTEIN CONFORMATION; VIRION; VIROLOGY;

EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HUMANS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN CONFORMATION; VIRAL ENVELOPE PROTEINS; VIRION;

EID: 85017404783     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep46374     Document Type: Article

References (41)

1. Feldmann, H., Sanchez, A., Geisbert, T. Filoviridae: Marburg and Ebola viruses. Fields virology. 6th ed. Philadelphia: Lippincott Williams, Wilkins 923-956 (2013).
2. Team, W. E. R. Ebola virus disease in West Africa-the first 9 months of the epidemic and forward projections. N. Engl. J. Med. 2014, 1481-1495 (2014).
3. Bornholdt, Z. A., et al. Structural rearrangement of ebola virus VP40 begets multiple functions in the virus life cycle. Cell 154, 763-774 (2013).
4. Beniac, D. R., et al. The organisation of Ebola virus reveals a capacity for extensive, modular polyploidy. PLoS One 7, e29608 (2012).
5. Booth, T. F., Rabb, M. J., Beniac, D. R. How do filovirus filaments bend without breaking Trends Microbiol. 21, 583-593 (2013).
6. Saeed, M. F., Kolokoltsov, A. A., Albrecht, T., Davey, R. A. Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes. PLoS Pathog 6, e1001110 (2010).
7. Takada, A., et al. A system for functional analysis of Ebola virus glycoprotein. Proc. Natl. Acad. Sci. USA. 94, 14764-14769 (1997).
8. Aleksandrowicz, P., et al. Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis. J. Infect. Dis. 204 Suppl 3, S957-67 (2011).
9. Hacke, M., et al. Inhibition of Ebola virus glycoprotein-mediated cytotoxicity by targeting its transmembrane domain and cholesterol. Nature communications 6 (2015).
10. Carette, J. E., et al. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 477, 340-343 (2011).
11. Côté, M., et al. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature 477, 344-348 (2011).
12. Nanbo, A., et al. Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathog 6, e1001121 (2010).
13. Flyak, A. I., et al. Cross-reactive and potent neutralizing antibody responses in human survivors of natural Ebolavirus infection. Cell 164, 392-405 (2016).
14. Zhao, Y., et al. Toremifene interacts with and destabilizes the Ebola virus glycoprotein. Nature 535, 169-172 (2016).
15. Hashiguchi, T., et al. Structural basis for Marburg virus neutralization by a cross-reactive human antibody. Cell 160, 904-912 (2015).
16. Murin, C. D., et al. Structures of protective antibodies reveal sites of vulnerability on Ebola virus. Proc. Natl. Acad. Sci. USA. 111, 17182-17187 (2014).
17. Hood, C. L., et al. Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: Implications for viral entry and immunogenicity. J. Virol. 84, 2972-2982 (2010).
18. Lee, J. E., et al. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454, 177-182 (2008).
19. Miller, E. H., et al. Ebola virus entry requires the host-programmed recognition of an intracellular receptor. EMBO J. 31, 1947-1960 (2012).
20. Schornberg, K., et al. Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J. Virol. 80, 4174-4178 (2006).
21. Chandran, K., Sullivan, N. J., Felbor, U., Whelan, S. P., Cunningham, J. M. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308, 1643-1645 (2005).
22. Dube, D., et al. Jh Kuhn u. Jm White (2009): The Primed Ebolavirus Glycoprotein (19-Kilodalton GP1, 2): Sequence and Residues Critical for Host Cell Binding. J. Virol. 83, 2883-2891.
23. O'Hearn, A., et al. Role of EXT1 and Glycosaminoglycans in the Early Stage of Filovirus Entry. J. Virol. 89, 5441-5449 (2015).
24. Malashkevich, V. N., et al. Core structure of the envelope glycoprotein GP2 from Ebola virus at 1. 9-A resolution. Proc. Natl. Acad. Sci. USA. 96, 2662-2667 (1999).
25. Agopian, A., Castano, S. Structure and orientation study of Ebola fusion peptide inserted in lipid membrane models. Biochimica et Biophysica Acta (BBA)-Biomembranes 1838, 117-126 (2014).
26. Weissenhorn, W., Carfí, A., Lee, K., Skehel, J. J., Wiley, D. C. Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain. Mol. Cell 2, 605-616 (1998).
27. Melito, P. L., et al. The creation of stable cell lines expressing Ebola virus glycoproteins and the matrix protein VP40 and generating Ebola virus-like particles utilizing an ecdysone inducible mammalian expression system. J. Virol. Methods 148, 237-243 (2008).
28. Tran, E. E., et al. Spatial localization of the Ebola virus glycoprotein mucin-like domain determined by cryo-electron tomography. J. Virol. 88, 10958-10962 (2014).
29. Tran, E. E., et al. Mapping of Ebolavirus Neutralization by Monoclonal Antibodies in the ZMapp Cocktail Using Cryo-Electron Tomography and Studies of Cellular Entry. J Virol. 90, 7618-7627 (2016).
30. Kastner, B., et al. GraFix: Sample preparation for single-particle electron cryomicroscopy. Nature methods 5, 53-55 (2008).
31. Penczek, P. A., Grassucci, R. A., Frank, J. The ribosome at improved resolution: New techniques for merging and orientation refinement in 3D cryo-electron microscopy of biological particles. Ultramicroscopy 53, 251-270 (1994).
32. Rosenthal P. B., Henderson R. Optimal determination of particle orientation, absolute hand, and contrast loss in single-particle electron cryomicroscopy. J Mol Biol. 333, 721-745 (2003).
33. Volchkov, V. E., et al. GP mRNA of Ebola Virus Is Edited by the Ebola Virus Polymerase and by T7 and Vaccinia Virus Polymerases 1. Virology 214, 421-430 (1995).
34. Henderson, R. The potential and limitations of neutrons, electrons and X-rays for atomic resolution microscopy of unstained biological molecules. Q. Rev. Biophys. 28, 171-171 (1995).
35. Zhao, Y., Ren, J., Harlos, K., Stuart, D. I. Structure of glycosylated NPC1 luminal domain C reveals insights into NPC2 and Ebola virus interactions. FEBS Lett (2016).
36. Gong, X., et al. Structural Insights into the Niemann-Pick C1 (NPC1)-Mediated Cholesterol Transfer and Ebola Infection. Cell. 165, 1467-1478 (2016).
37. Halfmann, P., et al. Replication-deficient ebolavirus as a vaccine candidate. J. Virol. 83, 3810-3815 (2009).
38. Ludtke, S. J., Baldwin, P. R., Chiu, W. EMAN: Semiautomated software for high-resolution single-particle reconstructions. J. Struct. Biol. 128, 82-97 (1999).
39. Frank, J., et al. SPIDER and WEB: Processing and visualization of images in 3D electron microscopy and related fields. J. Struct. Biol. 116, 190-199 (1996).
40. Beniac, D. R., Andonov, A., Grudeski, E., Booth, T. F. Architecture of the SARS coronavirus prefusion spike. Nature structural, molecular biology. 13 (2006).
41. Pettersen, E. F., et al. UCSF Chimera-a visualization system for exploratory research and analysis. Journal of computational chemistry. 25, 1605-1612 (2004).